🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11702+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11702 recruiting trials

RecruitingNCT07043491

Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy

👨‍⚕️ Hong Yang, PhD., Sun Yat-sen University📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06645899

Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism

🏥 F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore📍 41 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06523361

Contribution of Immersive Virtual Reality to a Standardized Rehabilitation Program for Upper Limb Chronic Pain: A Single-Case Experimental Design Study

🏥 University Hospital, Angers📍 2 sites📅 Started Nov 2024View details ↗
RecruitingNCT07036874

Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma

👨‍⚕️ Jimmy CT Lai, MB ChB, Chinese University of Hong Kong📍 1 site📅 Started Nov 2024View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT06762431

Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.

🏥 Vitebsk Regional Clinical Cancer Centre📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06121180

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

👨‍⚕️ Ahmad Tarhini, MD, PHD, Moffitt Cancer Center📍 4 sites📅 Started Nov 2024View details ↗
Phase 1, PHASE2RecruitingNCT06733935

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

👨‍⚕️ Nkarta Study Director, Nkarta, Inc.📍 14 sites📅 Started Nov 2024View details ↗
RecruitingNCT06636383

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

👨‍⚕️ Medical Director, Ultragenyx Pharmaceuticals Inc.📍 19 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06614777

Characterization of the Cytokine Profile and the Microbiome in Darier's Disease

👨‍⚕️ Juliette Mazereeuw-hautier, MD, University Hospital of Toulouse📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06298565

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

🏥 argenx📍 35 sites📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06488313

A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD

🏥 Arcturus Therapeutics, Inc.📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06645951

Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma

👨‍⚕️ Maria Luisa Brandi, MD, PhD📍 20 sites📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06812871

High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis

🏥 Sun Yat-sen University📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06585254

tVNS in Long COVID-19

👨‍⚕️ Benjamin H Natelson, MD, Icahn School of Medicine at Mount Sinai📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06694012

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

👨‍⚕️ Tomoshige Hayashi, MD, PhD, Osaka Metropolitan University📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06646497

Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06991400

Evaluation of Laparotomy With Trans-Amniotic Suture Placement in TTTS Surgery

🏥 Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06544265

SynKIR-310 for Relapsed/Refractory B-NHL

👨‍⚕️ Laura A Johnson, PhD, Verismo Therapeutics📍 5 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06563674

Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis

🏥 Chinese University of Hong Kong📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06657846

HRQoL and Financial Toxicity in Patients With VEXAS Syndrome

🏥 Gruppo Italiano Malattie EMatologiche dell'Adulto📍 17 sites📅 Started Nov 2024View details ↗
← PreviousPage 213 of 586Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →